Advertisement

Topics

AUSTRIANOVA Biotechnology GmbH Company Profile

05:16 EST 21st November 2017 | BioPortfolio

AUSTRIANOVA Biotechnology GmbH ranks among the leading Austrian biotechnology companies. Its offices and laboratories are located at the University of Veterinary Medicine in Vienna, where it was founded in 2001as the first University spin-off.The strategic and operative management of the company is still firmly in the hands of its founders, whilst its business area is the development of novel methods of tumour treatment based on cell and gene therapies.

Location

Veterinärplatz 1
Wien
A 1210
Austria

Contact

Phone: 43 1 25077 2601
Fax: 43 1 25077 2690
Email: office@austrianova.com


News Articles [262 Associated News Articles listed on BioPortfolio]

Ventaleon GmbH Reports Clear Clinical Progress And Additions To The Supervisory Board

- Last participant enters human challenge trial, data expected by year end 2017- New Supervisory Board members and investmentGemuenden, Germany, 12 October, 2017 - Ventaleon GmbH, a biotechnology comp...

Ventaleon GmbH Reports Clear Clinical Progress And Additions To The Supervisory Board

- Last participant enters human challenge trial, data expected by year end 2017- New Supervisory Board members and investmentGemuenden, Germany, 12 October, 2017 - Ventaleon GmbH, a biotechnology comp...

PharmaCyte Restructures Agreements with Austrianova to Strengthen Partnership

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

DGAP-News: GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institutional Sales, begleitet und waren signifikant

GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institution.....

British Columbia Securities Commission Revokes Cease Trade Order on PharmaCyte Biotech Securities

PharmaCyte Issues Corporate Overview and History PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular ...

APEC: Biotechnology Powerful Tool for Sustainable Agriculture

During the annual APEC High-Level Policy Dialogue on Agricultural Biotechnology (HLPDAB) Meeting in Can Tho, Vietnam on August 20, 2017, the agenda included agricultural biotechnology policies, promot...

Clinical Trials [48 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Companies [1372 Associated Companies listed on BioPortfolio]

AUSTRIANOVA Biotechnology GmbH

AUSTRIANOVA Biotechnology GmbH ranks among the leading Austrian biotechnology companies. Its offices and laboratories are located at the University of Veterinary Medicine in Vienna, where it was found...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

vitateq biotechnology GmbH

Vitateq Biotechnology GmbH, founded in 2000, is a research-driven enterprise with ultimate expertise in proteomics and protein quantitation. We will provide novel medical breakthrough by developing in...

Mecadi GmbH

Mecadi GmbH – Chemicals/Processing is a worldwide, business-independent operating service provider and manufacturer of the permeation and functional polymer field. We provide our customers with...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

More Information about "AUSTRIANOVA Biotechnology GmbH" on BioPortfolio

We have published hundreds of AUSTRIANOVA Biotechnology GmbH news stories on BioPortfolio along with dozens of AUSTRIANOVA Biotechnology GmbH Clinical Trials and PubMed Articles about AUSTRIANOVA Biotechnology GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AUSTRIANOVA Biotechnology GmbH Companies in our database. You can also find out about relevant AUSTRIANOVA Biotechnology GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record